Foresite Capital Opportunity Management V, LLC is 10% Owner at Theseus Pharmaceuticals, Inc. (THRX). They have made 4 open-market trades across 3 companies since 2021, most recently 2026-02-04.
CIK 0001792207
4 open-market purchases totalling $9.7M since 2021, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| GMTX | 2,928,750 | $39.5M |
| ALMS | 3,627,647 | $22.1M |
| PRDS | 8,773,134 | $18.9M |
| THRX | 4,108,796 | $16.7M |
| EIKN | 1,318,983 | $9.8M |
| Total | $107.1M |
Shares reported on the most recent Form 4, priced at the 2026-02-06 close.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.